BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17979680)

  • 1. Immune responses to gene product of inducible promoters.
    Le Guiner C; Stieger K; Snyder RO; Rolling F; Moullier P
    Curr Gene Ther; 2007 Oct; 7(5):334-46. PubMed ID: 17979680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.
    Favre D; Blouin V; Provost N; Spisek R; Porrot F; Bohl D; Marmé F; Chérel Y; Salvetti A; Hurtrel B; Heard JM; Rivière Y; Moullier P
    J Virol; 2002 Nov; 76(22):11605-11. PubMed ID: 12388721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo gene regulation using tetracycline-regulatable systems.
    Stieger K; Belbellaa B; Le Guiner C; Moullier P; Rolling F
    Adv Drug Deliv Rev; 2009 Jul; 61(7-8):527-41. PubMed ID: 19394373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgene regulation using the tetracycline-inducible TetR-KRAB system after AAV-mediated gene transfer in rodents and nonhuman primates.
    Le Guiner C; Stieger K; Toromanoff A; Guilbaud M; Mendes-Madeira A; Devaux M; Guigand L; Cherel Y; Moullier P; Rolling F; Adjali O
    PLoS One; 2014; 9(9):e102538. PubMed ID: 25248159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters.
    Pluta K; Luce MJ; Bao L; Agha-Mohammadi S; Reiser J
    J Gene Med; 2005 Jun; 7(6):803-17. PubMed ID: 15655804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatable gutless adenovirus vectors sustain inducible transgene expression in the brain in the presence of an immune response against adenoviruses.
    Xiong W; Goverdhana S; Sciascia SA; Candolfi M; Zirger JM; Barcia C; Curtin JF; King GD; Jaita G; Liu C; Kroeger K; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
    J Virol; 2006 Jan; 80(1):27-37. PubMed ID: 16352528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Five Years of Successful Inducible Transgene Expression Following Locoregional Adeno-Associated Virus Delivery in Nonhuman Primates with No Detectable Immunity.
    Guilbaud M; Devaux M; Couzinié C; Le Duff J; Toromanoff A; Vandamme C; Jaulin N; Gernoux G; Larcher T; Moullier P; Le Guiner C; Adjali O
    Hum Gene Ther; 2019 Jul; 30(7):802-813. PubMed ID: 30808235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.
    Stieger K; Le Meur G; Lasne F; Weber M; Deschamps JY; Nivard D; Mendes-Madeira A; Provost N; Martin L; Moullier P; Rolling F
    Mol Ther; 2006 May; 13(5):967-75. PubMed ID: 16442848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector.
    Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R
    J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of gene expression in vivo following transduction by two separate rAAV vectors.
    Rendahl KG; Leff SE; Otten GR; Spratt SK; Bohl D; Van Roey M; Donahue BA; Cohen LK; Mandel RJ; Danos O; Snyder RO
    Nat Biotechnol; 1998 Aug; 16(8):757-61. PubMed ID: 9702775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters.
    Bockstael O; Chtarto A; Wakkinen J; Yang X; Melas C; Levivier M; Brotchi J; Tenenbaum L
    Hum Gene Ther; 2008 Nov; 19(11):1293-305. PubMed ID: 19866492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased utility in the CNS of a powerful neuron-specific tetracycline-regulatable adenoviral system developed using a post-transcriptional enhancer.
    Lee YB; Cosgrave AS; Glover CP; Bienemann A; Heywood D; Hobson RJ; Uney JB
    J Gene Med; 2005 May; 7(5):576-83. PubMed ID: 15580589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses to lentiviral vectors.
    Follenzi A; Santambrogio L; Annoni A
    Curr Gene Ther; 2007 Oct; 7(5):306-15. PubMed ID: 17979677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction.
    Page A; Fusil F; Cosset FL
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33322556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetracycline-inducible transgene expression mediated by a single AAV vector.
    Chtarto A; Bender HU; Hanemann CO; Kemp T; Lehtonen E; Levivier M; Brotchi J; Velu T; Tenenbaum L
    Gene Ther; 2003 Jan; 10(1):84-94. PubMed ID: 12525840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Tetracycline-regulated Promoters in Lentiviral-based Vectors in Murine Transplantation Studies.
    Stahlhut M; Ha TC; Morgan M; Schambach A; Kustikova OS
    Curr Gene Ther; 2016; 16(4):242-248. PubMed ID: 27739375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and in vitro characterization of a single regulatory module for efficient control of gene expression in both plasmid DNA and a self-inactivating lentiviral vector.
    Ogueta SB; Yao F; Marasco WA
    Mol Med; 2001 Aug; 7(8):569-79. PubMed ID: 11591893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lentiviral vector system for coordinated constitutive and drug controlled tetracycline-regulated gene co-expression.
    Stahlhut M; Schwarzer A; Eder M; Yang M; Li Z; Morgan M; Schambach A; Kustikova OS
    Biomaterials; 2015 Sep; 63():189-201. PubMed ID: 26113075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Construct Polycistronic Doxycycline-Inducible Vectors Improve Direct Cardiac Reprogramming and Can Be Used to Identify the Critical Timing of Transgene Expression.
    Umei TC; Yamakawa H; Muraoka N; Sadahiro T; Isomi M; Haginiwa S; Kojima H; Kurotsu S; Tamura F; Osakabe R; Tani H; Nara K; Miyoshi H; Fukuda K; Ieda M
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28825623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of adenovirus-mediated tetracycline-controllable expression system.
    Mizuguchi H; Hayakawa T
    Biochim Biophys Acta; 2001 Nov; 1568(1):21-9. PubMed ID: 11731081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.